“VSSP Immunomodulator Reprograms Tumor-Promoting Macrophages to Tumoricidal State via IRF8- and PU.1-Dependent Mechanisms”

https://pubmed.ncbi.nlm.nih.gov/38117752

The provided scientific abstract describes a study which found that a novel immunomodulator called VSSP reprograms macrophages with tumor-promoting qualities towards a tumoricidal state via IRF8- and PU.1-dependent mechanisms, and this action is accompanied by an antitumor response.